Please provide your email address to receive an email when new articles are posted on . Adopting respiratory viral panel testing led to shorter antibiotic usage and a lower risk for C. difficile ...
Streamlining Respiratory Virus Testing with Molecular Diagnostics: Impact on patients and laboratory
Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...
Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
With Respiratory Season rapidly approaching the Northern Hemisphere, clinical laboratories must consider diagnostic strategies that produce maximum clinical utility, utilize efficient workflows, and ...
QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
Avian influenza can jump species from birds to humans, a fact that arouses concern for serious illness and broader human ...
Share on Pinterest Neosporin may be able to shield against some common viral respiratory infections, a preliminary study in mice and humans suggests. Image credit: Tim Boyle/Getty Images Viral ...
RSV, and PIV are associated with a higher risk for acute respiratory failure, highlighting the need for increased monitoring and preventive interventions in hospitalized patients. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results